Back to stock research

Verified earnings summary

Research updated: Jul 12, 2026, 12:00 AM UTC

ELV Q1 2026

Elevance Health's first-quarter 2026 update reflected commercial and government health-benefit execution, expanding Carelon services and continued attention to Medicaid rates and medical-cost trends.

This page provides a source-verified release summary. It does not display a normalized metric table or post-earnings market reaction until those fields are independently verified.

Constructive signals after the release

  • Pharmacy, behavioral-health and care-delivery services can grow within Elevance plans and with external clients.
  • Disciplined pricing and product design can preserve margins as utilization changes.
  • Scale in Medicaid and Medicare can support membership relationships when rates reflect care costs.

Risks that still need monitoring

  • Medicaid rate adequacy

    State rates may lag acuity changes after eligibility redeterminations, compressing margins.

  • Medical utilization

    Higher outpatient, pharmacy or specialty-care use can exceed premium assumptions.

  • Regulatory exposure

    Payment rules, risk adjustment and benefit mandates can alter product economics.

Primary sources

Elevance Health Reports First Quarter 2026 ResultsElevance Health, Inc. · earningsVerified

Fetched: 7/12/2026, 12:00:00 AM UTC

Published: 4/22/2026, 12:00:00 AM

Open original source
Elevance Health, Inc. Investor RelationsElevance Health, Inc. · companyVerified

Fetched: 7/12/2026, 12:00:00 AM UTC

Open original source
Elevance Health SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified

Fetched: 7/12/2026, 12:00:00 AM UTC

Published: 4/22/2026, 12:00:00 AM

Open original source

Continue research

Open risk researchReturn to full stock research